Biokhimiya/Biochemistry 1993-10-01

[Substrate specificity of T4 RNA-ligase: the role of a purine nucleotide base in forming a covalent AMP-RNA-ligase complex].

BA Iuodka, DIa Labe_kite, SI Sasnauskene

Index: Biokhimiia 58 , 857-865, (1993)

Full Text: HTML

Abstract

The NTP binding site of bacteriophage T4 RNA-ligase (EC 6.5.1.3) was studied using several ATP analogs modified in the purine moiety of the nucleotide at positions 1, 2, 6 and 8: adenosine-N'-oxide 5'-triphosphate (I), 6-chloropurine riboside 5'-triphosphate (II), 6-mercaptopurine riboside 5'-triphosphate (III), 1,N6-ethenoadenosine 5'-triphosphate (IV), 8-sulphoadenosine 5'-triphosphate (V), 8-bromoadenosine 5'-triphosphate (VI), inosine 5'-triphosphate (VII) and guanosine 5'-triphosphate (VIII). For all of the ATP analogs under study a reversible inhibition was demonstrated. These analogs appeared to be competitive inhibitors of the T4 RNA-ligase adenylation reaction and only V, VI and VII were efficient as substrates. The kinetic parameters for the competitive inhibition, (I50, Ki) were determined. A putative structure for the T4 RNA-ligase active site was proposed.


Related Compounds

Related Articles:

Evidence on the existence of a purine ligand induced conformational change in the active site of bovine pancreatic ribonuclease A studied by proton nuclear magnetic resonance spectroscopy.

1982-08-31

[Biochemistry 21(18) , 4290-7, (1982)]

Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.

2007-05-15

[Biochem. Pharmacol. 73 , 1558-1572, (2007)]

Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents.

2007-05-01

[Bioorg. Med. Chem. Lett. 17 , 2470-3, (2007)]

Introduction of a benzoyl group onto 6-chloropurine riboside in aqueous solution and its application to the synthesis of nucleoside derivatives.

2000-01-01

[Nucleic Acids Symp. Ser. 44 , 103-104, (2000)]

Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design.

1999-03-30

[Proc. Natl. Acad. Sci. U. S. A. 96 , 3531-3536, (1999)]

More Articles...